Wednesday, September 7, 2005

WHAT DOES THE INDO-US DEAL ON AGRICULTURE GIVE?

Suman Sahai

On his visit to the US, the Prime Minister made a deal on nuclear energy and another on agriculture. Because of the furor over the former, the latter seems to have gone unnoticed. It should not be. India has asked for US help to develop drought resistant crop varieties; reduce post harvest losses, take information about improved technologies directly to farmers and provide training in sanitary and phytosanitary standards. Training to improve food standards will be welcome since India is very poor in this regard .Indian exports are returned, sometimes because buyers use phytosanitary standards as a protectionist tool but also because the products are contaminated or substandard.

Phytosanitary training alone will not enable Indian farmers to participate more fully in global trade, as is projected. That will only happen if domestic subsidies and tariffs are reduced by the US and EU. The subsidy impediments to those markets are being negotiated currently, without any success whatsoever, in the agriculture negotiations prior to the December WTO Ministerial in Hong Kong.

Although not stated explicitly, the agriculture pact deals essentially with agricultural biotechnology. The US really does not have anything of relevance to offer Indian agriculture and small farmers. The technologies available in US laboratories are known and there is nothing of importance to Indian agriculture which is plagued by different problems, like lack of credit and crop insurance, spurious seeds and substandard inputs.

Then there is the problem of Intellectual Property Rights. Almost all products and processes in agricultural biotechnology are protected by patents and practically controlled by six multinationals. The technologies developed in American universities have also slipped into their hands thanks to the Bayh- Dole Act which allows universities to transfer technologies generated with public funds, to the industry.

A collaboration with the US would make sense only if technologies were to be available free of patents, if not, there is no need for a special deal. Monsanto’s Bt technology, for instance, is available to anyone who can pay their license fees. A deal to use US technology is likely to increase the pressure on India for introducing seed patents and removing the ban we have placed on the American terminator technology. The Americans favor patents on seeds as against Plant Breeders Rights which is the Indian legislation.

Regarding the special focus on developing drought resistant varieties, it is worth recalling that globally this research has been entrusted to the Consultative Group on International Agricultural Research (CGIAR). The principal mandate of the public sector CG system with its strength of over 8000 scientists is to develop drought resistant plant varieties for developing countries. If at all India needs to use the transgenic approach to drought tolerance, its natural partner is the CG system, not the US.

If it is post harvest losses we are concerned about, there are relatively straightforward solutions. We need scaling up of our food processing sector to add shelf life to agricultural produce. More and better warehouses for storing our buffer stocks and better transportation facilities,( less broken trucks that leak the grain as they transport it) are guaranteed to reduce post harvest losses. The main post harvest technology that the US has is the delayed ripening technology that was used to create the ‘Flavr Savr’ tomato. Flavr Savr was abandoned largely because of health fears after it was found that laboratory rats fed on the GM tomato died or suffered health damage. Flavr Savr has never been revived and we should be cautious that we do not become the dumping ground for failed and dangerous technologies.

The part that mystifies most is the assertion that the Indo –US collaboration will take information and know-how directly to the farming community. How does it propose to do this ? Given the fact that we have dismantled the agriculture extension service and the connections between the laboratory and the farmers’ fields have been snapped many years ago, through which mechanism will these allegedly beneficial technologies be taken directly to the farming community? The Krishi Vigyan Kendras (KVKs) , set up as technology absorption hubs in rural areas have long ago fallen into disuse and there is no provision to revive them.

The real problem in Indian agriculture today is the appalling state of the agricultural research system , which is moribund, lacking innovative capacity and engaged to a large extent, in copy cat research. Over a third of all the research being done on GM crops in the country is based on Monsanto’s Bt gene, as though the only problem we have in Indian agriculture is the bollworm (the pest against which Bt is partly effective).

The Indo- US deal will not solve our problems nor introduce the desperately needed spirit of independent scientific enquiry that seems to have abandoned the ICAR system. Instead, a radical overhaul of the country’s agricultural research is needed. Heads must roll, the stables cleaned up, the system revamped and good scientists, of which there are plenty, brought in to lead the world class research that our scientists are capable of. That, and not a dubious pact in agriculture is what the country needs today.

Thursday, July 21, 2005

THE PM’S INDO-US DEAL ON AGRICULTURE

Suman Sahai

The Prime Minister took along a number of scientific and technical people on his visit to the US with the aim of entering into technical collaboration with the Americans. Apart from the much discussed pact on nuclear energy, there is also a ‘second generation collaboration on agriculture’. The relevant extract from the Prime Minister’s speech reads like this “ …. have decided to launch a second generation of India-US collaboration in the field of agriculture. The new initiative will focus on basic and strategic research for sustainable development of agriculture to meet the challenge of raising productivity in conditions of water stress. It seeks to take information and know-how directly to the farming community and promote technologies that minimize post harvest wastage and improve food storage. It will also help Indian farmers to meet phytosanitary conditions and enable them to participate more fully in global agricultural trade.

The key areas the Prime Minister’s advisors have decided to focus on for seeking US help, are sustainable agriculture; developing drought resistant crop varieties; reducing post harvest losses of agricultural produce by improving the shelf life of such produce; taking information about improved technologies directly to farmers and training in the WTO requirement of maintaining adequate sanitary and phytosanitary standards for agricultural produce. The last, training and capacity building in achieving hygiene and purity standards for agricultural produce that is globally acceptable will be welcome since India is very poor in this regard and could do with some international level training on achieving sanitary and phytosanitary standards in agriculture. Indian produce is often returned by international buyers, sometimes because they use phytosanitary standards as a protectionist tool to protect domestic producers but partly also because the products are contaminated or substandard.

It is when we take the phytosanitary point further that we realize that it is actually a blind alley which does not take us anywhere. According to the PM’s speech, collaboration on phytosanitary training will enable Indian farmers to participate more fully in global trade. Yet, there is no mention of the only factor that will enable us to export our goods and that is reducing tariffs and bringing down the large domestic and export agriculture subsidies which are the barriers to our participating in global trade. The astronomic agriculture subsidies in the US and EU make Indian products expensive and unviable in their markets.So, after training in phytosanitary standards we may end up with better agricultural produce ( a desirable enough goal), but let us not fool ourselves that this will open up American and European markets for us. The subsidy impediments to those markets are being negotiated currently, without any success whatsoever, in the run up to the Agreement on Agriculture negotiations prior to the December WTO Ministerial meeting in Hong Kong.

Now let us examine the rest of the agenda, which although not stated explicitly, deals essentially with agricultural biotechnology. Does the US have anything of relevance or importance to offer Indian agriculture and small farmers? The technologies available in US laboratories in the private and public sector are known since many years. There is nothing new there nor anything of terrible relevance to the problems of Indian agriculture. An important problem with using US technologies is the question of Intellectual Property Rights. Almost the entire spectrum of technologies in agricultural biotechnology is protected by patents. In fact, the technology can be said to be almost completely in the hands of six multinational concerns, Monsanto, Syngenta, Dow, DuPont, Bayer and BASF. The public sector technologies that were developed in American universities and research institutions have also slipped into the hands of the industry thanks to the Bayh- Dole Act. This legislation allowed universities to transfer technologies generated with public research funds, to the industry, resulting in public institutions granting (exclusive) licenses to the corporations, on almost all key technologies. So at best, the US can give us access to its patented and expensive GM technologies.

Any talk of Indo- US collaboration would make sense only if the technologies were to be available for free or on highly concessional rates. If we have to access a technology at market rates, there is no need for a special collaboration. Agbiotech technologies, like Monsanto’s Bt technology, are available to anyone who can pay the license fees that they charge. The other IPR question is that of seed patents. The Americans are known to favor patents as against Plant Breeders Rights which is the legislation that we have in India. The corporations (backed by the US) have been lobbying for a change in India’s patent laws that would make genes and seeds patentable. A collaboration to use their technology is likely to increase the pressure on India for introducing seed patents and perhaps removing the ban we have placed on the terminator technology. The terminator technology is jointly owned by the US government. None of these developments will be in the interest of Indian farmers or national food security.

Regarding the special focus that has been placed on the collaboration with the US ,to develop drought resistant varieties, it is worth recalling that this research has been entrusted to the institutions of the Consultative Group on International Agricultural Research (CGIAR). Instead of frittering small research grants in many laboratories, the international research community (including India) decided that the principal mandate of the CGIAR with respect to GM crops would be to develop drought tolerant varieties.

The CG system with its strength of over 8000 scientists and researchers is a public sector research agency whose mandate is to do publicly accessible research ( without being patented) to serve public causes and farmers’ needs in developing countries. If at all India needs to use the transgenic approach to drought tolerance research, its natural partner is the CG system, not the US.

It is quite another matter that experts in the field of water stress have pointed out repeatedly, that a plant’s response to water stress is far too complex and dependent on often unpredictable factors, to be fixed by a transgenic approach, shooting some foreign gene into a plant. There are far greater chances of success in going the conventional way; exploring the available genetic biodiversity of the particular crop, selecting promising varieties and breeding drought tolerant varieties which contain an optimal combination of genes that will help the plant to withstand water stress in a variety of ways. We need to remember that all drought tolerant crop varieties in existence today have been bred by conventional breeding. Nothing has yet emerged from the years of expensive transgenic research directed towards this goal.

Then we have the focus on reducing post-harvest losses and improving food storage. The only technology that the US has in this connection is the delayed ripening technology that they used to create the ‘Flavr Savr’ tomato, a tomato that would remain firm and not rot easily. This technology which looked promising failed for a variety of reasons, the most important of which were food safety concerns raised after feeding trials. Rats fed with Flavr Savr tomato in laboratory experiments showed health damage. Flavr Savr has never been picked up again, not even in the US and we should be cautious that we do not become the dumping ground for a failed and dangerous technology.

If it is post harvest losses we are concerned about, there are relatively easy solutions with no connection to Agbiotech. We need substantial investment and scaling up of our food processing sector, to add value to agricultural produce that otherwise rots under poor quality storage conditions or because it cannot reach markets in time. The Indo -US collaboration would be useful if it brought advanced food processing technology that would allow value addition of fruits and vegetables locally, increasing farm incomes.

This is a more realistic approach to reducing post harvest losses than a potentially dangerous, expensive and failed agbiotechnology from the US. More and better warehouses for storing our buffer stocks and better transportation facilities,( less broken trucks that leak the grain as they transport it) are guaranteed to reduce post harvest losses. The fact is that we know the causes of our post harvest losses and we also know the solutions. It is hard to see where a genetic engineering approach fits here.

The part that mystifies most is the assertion that the Indo –US collaboration will take information and know-how directly to the farming community. How does it propose to do this ? Given the fact that we have entirely dismantled the agriculture extension service and the connections between the laboratory and the farmers’ fields have been snapped many years ago, through which mechanism will these allegedly beneficial technologies be taken directly to the farming community? The Krishi Vigyan Kendras (KVKs) , set up as technology absorption hubs in rural areas have long ago fallen into disuse and there is no provision to revive them.

The real challenge before Indian agriculture is the weakened to the point of becoming defunct nature of the agricultural research system. The system is moribund, lacking innovative capacity and engaged to a large extent, in copy cat research. Over a third of all the research being done on GM crops in the country is based on Monsanto’s Bt gene, as though the only problem we have in Indian agriculture is the bollworm (the pest against which Bt is partly effective). Collaboration with the US will not solve these problems nor introduce the desperately needed spirit of independent scientific enquiry that seems to have abandoned the ICAR system. Many proposals have been made in recent years to overhaul the Indian Council of Agricultural Research and the agricultural universities, to make them responsive to the country’s needs. Its time to take action on those. Heads must roll, the stables cleaned up, the system revamped and good scientists (of which there are plenty) brought in to lead the world class research that our scientists are capable of conducting. No amount of Indo- Us collaboration will solve these problems, only resolute will and action will.

Saturday, October 2, 2004

THE GREEN REVOLUTION AND THE GENE REVOLUTION

Suman Sahai

Agbiotechnology is presented in many forms; the most common being that it will solve world hunger. To reinforce this claim, there is an interesting word play at work. Agbiotechnology is referred to as the ‘Evergreen Revolution’ or the ‘Gene Revolution’; both terms are an attempt to link Agbiotech with the Green Revolution. In the view of most political leaders, policy makers, farmers and citizens, the Green Revolution was a positive happening that brought benefits. It did in fact increase food production, principally cereal production. It made India independent of food exports and firmed up its political spine. It ensured surplus grain that could be stored in buffer stocks to be rushed where need arose and it tried to ensure that famines were not a feature of the Indian reality.

These gains were so visible that the downside, the unequal distribution of the benefits, of land and water degradation, the accompanying loss of genetic diversity and the persisting endemic hunger and poverty, could not take the shine off the Green Revolution. Because of this positive image, the promoters of Agbiotech draw semantic parallels, invoking the earlier agricultural revolution. The subliminal message is, if the Green Revolution brought so many benefits, the Evergreen Revolution would bring all those in perpetuity. The word play has actually been quite successful. Political leaders and policy makers carry over the positive association with the Green Revolution to the Evergreen one. If the earlier version brought such benefits, the newer one (more precise, with greater possibilities, as the industry says) would surely bring even greater benefits to the farmers and the poor. Conveniently left out of this portrayal are the essential and crucial differences between the two ‘Revolutions’.

The Green Revolution was a publicly owned technology, belonging to the people. The research was conducted with public money to fulfil a public need, inadequate food production, and it created public goods to which everyone had access. There were no Intellectual Property Rights (IPR), no patents vested in multinational companies, no proprietary technologies or products. If there was ownership of the GR, it was vested in the farmer. Once the seed reached the farmers, it was theirs; they moved it where they wanted. Therefore despite its faults, the Green Revolution addressed farmers needs and India’s food production showed an upward curve.

The Evergreen Revolution is almost the exact opposite. It is a privately owned technology. Six corporations (Monsanto, Syngenta, Bayer CropScience, DuPont , Dow and BASF Plant Science) control practically the entire research and output in the field of transgenic plants. Processes and products, including research methodologies are shackled in patents and the farmer has no say, let alone any control. The technology creates only private goods that can be accessed only at significant cost (a bag of Mahyco- Monsanto’s Bt cotton seeds in India costs Rs. 1600 as compared to between Rs. 300 to Rs 400 for superior varieties produced locally).

The seed belongs to the company, which strictly controls its movement. With the development of the popularly termed ‘terminator’ or sterile seed technology, the farmer is reduced to a helpless consumer, not a partner as in the case of the GR. The Evergreen Revolution has in its 20 years, not yet produced a crop variety that has any direct connection to hunger and nutritional needs. The most prevalent crops remain corn, Soya, cotton and canola and the dominant traits are herbicide `tolerance and insect resistance. Despite its other faults, the Green Revolution was able to put out a number of crop varieties in a short span of time that enabled direct yield increases, which brought immediate benefits to farmers. That in short is the contrast between the two Revolutions, so assiduously camouflaged by the Agbiotech spinmeisters.

India had participated enthusiastically in the Green Revolution and is on its way to equally enthusiastically embrace the Gene revolution or Agbiotechnology. Yet there is little debate in the country on whether any lessons have been learnt from the Green Revolution. There is even less debate between policy makers and other stakeholders about the path that Agbiotechnology should take in India. There is no consultation with the public like in many other countries, for example in Europe or any sharing of information, as is done in almost all countries that are implementing GM technology. The Department of Biotechnology has promoted research projects randomly in universities and research institutions, without any assessment of farmers’ needs and the best way to fulfil them; civil society has been uneasy with the lack of transparency and the lack of competence in regulatory bodies; the media is largely uninformed and political leaders remain unaware of the direction this new and controversial technology was taking in India and have no say in determining what it should or should not do.

It is time that the country gave itself a well thought out national policy on agricultural biotechnology. The policy should be framed after widespread consultations with a range of stakeholders. The process of consultations should be inclusive and transparent, allowing a range of expertise and insights to be brought into the decision making process. The greater the ownership of the outcome of the consultative process, the better will be the acceptance of the policy that is framed.

Friday, August 20, 2004

IT IS NOT WISE FOR THAILAND TO GM TAG ITS JASMINE RICE

Suman Sahai

The National Biotechnology Committee of Thailand plans to use GM technology to improve the quality and productivity of jasmine rice, ordinary rice and rice for food processing. The plan for jasmine rice is to use genetic engineering and molecular breeding to introduce resistance to flood and drought. This is not a wise move. Flood and drought tolerance can be more easily achieved by conventional breeding than by genetic engineering and the price for adding the GM tag may be too high.

With the GM tag, Thailand would jeopardise the special status accorded to Jasmine rice. It would also risk its rice gene pools since the contamination of other rice varieties and their natural relatives with foreign genes from the GM Jasmine rice would be a certainty.

Thailand has been fighting to protect its jasmine rice from biopiracy. It has contested claims by US based companies to use its name in a trademark violation called ‘passing off’ as ‘Jasmati’. The jasmine rice of Thailand, is claimed by the Thai as a special Thai product and the Thai have sought to exercise their rights over this product invoking the IPR protection called ‘Geographically Indicated (GI) Rights, in the WTO. Provided in Articles 22, 23 and 24 of the TRIPs chapter, GI protection can be claimed by countries for products that are exclusively associated with their region. At present, GI protection is available only for wines like Champagne and Spirits like Scotch whiskey. Developing countries are however fighting hard to increase the scope of GI protection so that products of interest to them can also be given GI IPR protection and be considered exclusively theirs. India for example has an interest in Basmati rice and Darjeeling tea, to name just two products. Thailand has claimed Jasmine rice as its own.

Once Jasmine rice becomes a GM variety, not only is Thailand likely to lose its markets in those countries (particularly Europe) that are not favourably inclined to GM food, it will also forfeit its claim to GI protection. Is it willing to do that? Have the Thai authorities thought through the consequences of turning their premium Jasmine rice into a controversial GM food? The Thai thinking is probably like India’s, which has invested in Bt Basmati. The Basmati project in India has been put on hold after protests from rice traders and groups like Gene Campaign which has pointed out that Basmati would acquire an ‘untouchable’ status if it were tainted with the GM label. The intention is to increase production of a premium product like Basmati or Jasmine rice and thus increase earnings in an assured high-end market. This will backfire because consumers will shy away from the GM label.

Jasmine rice is not the food of the masses. It is an expensive premium product, much like India’s Basmati rice. The poor, who cannot afford its high price, consume neither, so there is no pressure to increase its production from the point of view of food security. Like truffles and caviar, Jasmine rice is a luxury food, which brings good revenue for its farmers. Tampering with it by adding the GM label is likely to jeopardise the assured earnings of the farmers who grow Jasmine rice.

Apart from the issue of special protection under GI , in WTO/TRIPs, is the question of environmental safety . Thailand belongs to the Indochina Centre of biological diversity. It has a great deal of diversity in rice, which includes farmer varieties, landraces and wild relatives of rice. One of the principle environmental concerns with respect to GM crops is the matter of gene flow and its consequences for agro-biodiversity. It is a fact of biology that pollen will fly around and along with pollen will fly around the foreign genes contained in the pollen of the GM crop. When there are other rice varieties and wild relatives in the vicinity, the pollen with foreign genes can cross pollinate with them, thus transferring the foreign genes to them . Although rice is largely a self-pollinated crop, high enough rates of cross-pollination have been recorded to cause concern for genes to be transferred from the GM Jasmine rice to the neighbouring rice varieties and the natural rice gene pool.

We do not know yet what the long term consequences of such gene transfer and gene introgression can be since no studies have been done under developing country conditions. Western nations have done gene transfer studies on crops of interest to them but developing countries have not done enough of this kind of basic work. If there is no impact in the long term or the impact is harmless, it does not matter. But should we discover that there is a negative impact, we would have possibly jeopardised the integrity of one of the most important gene pools in the world. The consequences for food security could be unimaginable if the rice gene bank in nature were to be endangered.

The implementation of GM technology is meant be guided by the Precautionary Principle. This Principle was formulated because we know so little about the long-term impact of cultivating GM crops. The Precautionary Principle says that if we do not know enough or if there is uncertainty about the safety of a process or product, then it is best to avoid that product. We know practically nothing about the behaviour of GM rice in a natural agricultural environment, particularly in a centre of diversity. The precautionary principle dictates that we do not take a chance. In my view, no nation should cultivate a GM crop for which it is a centre of diversity. Mexico has taken this intelligent decision. Since 1998, the Mexican government has placed a ban on the cultivation of GM corn since Mexico is a centre of origin and diversity for corn. In 2002, the Mexicans went a step further; they banned even research on GM corn, since they were not prepared to take a risk with their corn gene pool. China does not allow the cultivation of GM soybean for which it is a centre of origin and diversity. Thailand and India should learn from these countries and leave GM rice alone.

Monday, June 14, 2004

The Agbiotech Task Force Report

Suman Sahai

The government had appointed a Task Force to examine Agbiotechnology and make recommendations for its implementation. The Task Force headed by Dr. MS Swaminathan was given the following mandate: to formulate a long-term policy on applications of biotechnology in agriculture; make suggestions for harmonizing decision making; recommend a role for the Agriculture Ministry and generate awareness.

.

The importance of the recommendations of the Task Force lies in the fact that this is the first effort to formulate a policy. Civil society organizations have been frustrated in the past by the refusal of the Department of Biotechnology (DBT) to engage in any dialogue on public concerns or be receptive to any suggestions for improving a clearly unsatisfactory system. The former head of DBT is famously on record for doggedly insisting that India did not need a biotechnology policy when all around her, from the most vocal protagonists to the most determined opponents, were demanding a national policy.

The report’s basic recommendation is that the national policy should seek the ‘economic well-being of farm families, food security of the nation, health security of the consumer, protection of the environment and the security of our national and international trade’. If the recommendations of this Task Force are upheld, no policy implementation can deviate from these goals.

The report highlights the need to link transgenic research in India to the international market. Transgenic research should not be done on crops that we sell in the international market, like soybean, Basmati rice and Darjeeling tea. Readers will recall the hare brained schemes of the DBT to promote Bt Basmati and introduce the beta-carotene construct of Golden Rice into Basmati rice. Nobody seemed to be thinking that we are exporters of Basmati (and other) rice as well as soybean (to special niche markets) and that our major trading partners are all rejecting GM foods. So who would buy our Bt Basmati or our GM Soya?

The report is critical of the prevailing gung-ho climate when any proposal for research on a GM crop, however nonsensical the goal, is likely to get sanctioned, often at the cost of conventional research which is more likely to yield results of relevance. It recommends that all alternatives to GM technology should be examined and the GM route used only when other options are not available. There is an explicit injunction against using negative GM traits like herbicide tolerance that can reduce employment ( by taking away the opportunity to earn wages by weeding) and impinge on rural livelihoods (by destroying vegetation that is used as nutritious leafy greens or fodder to support livestock).

The report says that our policy on transgenics should be sensitive to biodiversity conservation and the socio-economic context of our composite agrarian system. In other words, small farmer interests have to be protected. In recommending the breeding of both varieties and hybrids and supporting apomixis as a strategy, the recommendation is clearly in favor of the farmers’ right to save seed from previous harvests.

The recommendation that Centers of Origin and diversity like the Jeypore tract for rice must be protected, is an important one. However the proposed mechanism for earmarking GM and non-GM zones does not appear to be feasible. If the cultivation of GM rice is permitted in certain areas but not in the diversity rich areas of Orissa, Jharkhand and Chattisgarh, there is no way of preventing GM rice landing up there. Foreign genes in that case are bound to move to wild relatives of rice in its center of origin. We have seen the speed with which the illegal Bt cotton originally put out by Navbharat seed company has spread to almost all cotton growing areas, despite the fact that its planting is illegal. Similarly, contamination of native corn in Mexico has taken place inspite of the ban on the cultivation of GM corn in the country. Zoning or segregation is unlikely to work. The only way of protecting native germplasm from foreign genes with likely negative impacts is to disallow the GM version of that particular crop.

I have a disagreement on the edible vaccine strategy that forms part of the report. I do not believe India should invest in edible vaccines since it will be impossible to keep vaccine bearing fruit separate from ordinary fruits. Mixture with the food chain is inevitable since one bunch of bananas looks like another. It would be even harder to segregate grains. In the US, Starlink corn, which was not allowed as food but only animal feed, was found mixed up with food corn. In the Prodigene case in the US, a GM corn carrying pig vaccine was found mixed up with soybean for human use, showing segregation is not possible even in the highly regulated conditions of US agriculture. India should have a strict policy of allowing the expression of pharmaceutical molecules like vaccines only in non-edible plants.

With respect to regulation, the report has suggested much needed technical competence and transparency. I would have liked to see a greater role for civil society, as is the case in the Philippines and other ASEAN nations. The structure of the regulatory authority would benefit from greater autonomy. The regulatory structure should be demonstrably competent and independent to inspire confidence. It should be able not just to assess Biosafety, environmental and long term ecological impact but also other aspects like social and economic impacts, particularly the impact on small farmers, of the introduction of a particular GM crop. In my view, it would be best to divide the regulatory function into two parts, one Advisory, the other Statutory.

Advisory Body

The Advisory body should have a broad based multidisciplinary membership that includes all relevant scientific disciplines, social scientists, environmentalists, civil society groups, members of farming and adivasi communities, representatives of panchayati raj institutions, and legal experts. A person of the highest technical calibre who has experience in the regulation of GM crops should head the body

Statutory Body

The statutory body should be an independent body staffed by people skilled in Bio safety Assessment, Environmental Assessment and Environmental Impact Assessment. This body should have overall responsibility for all aspects of risk assessment, risk management, risk communication leading up to decision-making about the safety of a GM crop for the environment, human and animal health and post release monitoring. It is important to ensure that there is no conflict of interest and rules should be framed in a clear and unambiguous manner so that it is not possible to stack the Agency with any particular kind of people. Clear-cut channels should be created for the public to participate in the decision-making process and to voice concerns. There should be an annual review of the decisions taken on GM products and the rationale for these decisions. This review should be presented to Parliament.

Overhauling the regulatory system from its currently appalling state should be high priority. Hopefully the process begun by the Task Force will help to establish a competent and participatory system and a more responsible way of evaluating which GM crops could be relevant for Indian farmers.

Tuesday, May 4, 2004

WHY GM RICE ANYWHERE THREATENS INDIA

Suman Sahai

The proposed permission to Bayer CropScience Ltd. (which has been held up for now), for importing genetically modified herbicide tolerant rice (LLRice62) into the EU, as animal feed has implications not just for the EU, but far more importantly, for the rice growing regions of the world. Such a step would have grave implications for the natural rice germplasm in rice growing areas of the developing world that are the centres of origin and diversity. It is noteworthy that Bayer’s application is only for the import and processing of genetically modified (GM) rice into the European Union. Bayer has not sought permission for cultivation because it doesn’t intend to grow this GM rice in Europe although rice is cultivated in five EU member states – Italy, Spain, Greece, Portugal and France. Therefore the rice that Bayer proposes to import would have to be grown in developing countries like India.

Gene Campaign, which is asking for a moratorium on the cultivation of GM crops in their centres of origin and diversity, is alarmed that India could be tempted to produce GM rice for the EU market. It would be particularly ironic that India and other centres of diversity for rice could end up jeopardising their principal food source for producing animal feed to support the meat consumption of the west. There is something decidedly unethical about Bayer wanting to protect the few rice-growing states of the EU by not seeking permission for cultivation in Spain, Italy, Greece, Portugal or France. In applying to import GM rice for animal feed from developing countries, the corporation demonstrates its callous disregard for human life and food security in the poorer regions of the world. It is willing to put at risk the food staple of these poor people to support the unsustainable consumption of the west.

There is reason to be concerned about the potential adverse impacts of Bayer’s application for developing countries like India where rice is grown and where the regulatory framework for GMOs is weak or even non-existent. Farmers in such countries are not aware of the larger issues and the possible implications of GM rice in their fields and thus not really able to take an informed decision on whether or not to grow the rice. Opening the EU market for GM rice would be a lure for rice producing nations to cultivate GM rice for the export market. It would be relatively easy to sell this proposal in the domestic context, because of the potential for export earnings, but this would overlook the very critical threat of genetic contamination in the rich rice diversity areas in India like Orissa, Jharkhand and Chattisgarh.

Gene Campaign stresses that India is one of the centres of origin and diversity for rice and has substantial concerns about the possibility of genetic contamination of native rice genepools. A centre of origin is the region from where a particular crop originated a few thousand years ago when indigenous communities developed edible crops from the wild plants found in the forest. The wild relatives and therefore the maximum diversity of crops is found in their centres of origin.

The importance of protecting the genes in centres of origin as a world resource for global food security cannot be overstated. Resistance to two of the four main diseases afflicting rice, comes from a single landrace, Oryza nivara that is found in central India.

Centres of origin are considered high-risk areas for GM crops because if the foreign genes contained in the GM variety were to move into the natural gene pool, the results could be potentially catastrophic. Scientists promoting Agbiotech argue that rice is a self-pollinating crop and will not accept outside pollen and genes. This is simply not true. Several studies exist showing cross-pollination happens in rice. Recent reports from China and Latin America are showing that gene flow between GM rice and other rice happens at rates that are high enough to cause concern. Experiments have also found that the herbicide tolerance gene can move to native varieties and create new, difficult to control, weeds. There are other studies that show that the introduction of foreign genes by the process of genetic engineering can cause a phenomenon called ‘gene silencing’ in the plant that is receiving the foreign gene. This means certain genes in the plant will become silent ( non-functional) and not produce what they normally should. Gene silencing could have very grave implications if it were to spread to the natural gene pool by careless scientists.

Genetic diversity is crucial for the long-term survival of any crop. When a crop variety somewhere becomes vulnerable either due to the onslaught of a disease it cannot fight, or because the soil has become water logged or alkaline, scientists need to breed another variety of the crop for that region. They do this by searching for suitable genes in related varieties and the natural gene pool. If these genes were to be unavailable, the vulnerable variety would perish, depriving people in that region of food. That is why it is important to maintain genetic diversity. If GM rice were to harm the native gene pool of rice by making certain genes non-functional or changing the normal functions of other genes, it would have terrible implications for the food security of the rice eating regions of the world.

Gene Campaign considers GM rice to be a particularly sensitive issue for India and one where the Precautionary Principle must be invoked because the implications of genetic contamination in rice can be very grave indeed for farmers and for food security. No studies are being conducted in India to understand the levels of gene flow in rice, to assess what would happen if foreign genes were to escape from GM rice to farmers’ varieties and wild relatives of rice.

The Agbiotech industry is quick to project that there is no danger of foreign gene flow in rice because it is a self pollinating crop ( and would not accept genes from GM crops), but evidence is mounting that this is not the case. Recent studies show that gene flow in rice happens and should be cause for concern.

Recent research from China demonstrates that transgene escape from cultivated rice to wild rice (Oryza rufipogon) occurs at the rate of up to 2.19 % in the field[1]. This is quite significant for rice growing regions and would mean that foreign genes could spread easily in the native population. Another recent study done in Latin America to look at the transfer of herbicide tolerant genes ( same as in Bayer’s rice) to wild relatives of rice, showed that this transfer does indeed take place . The study also predicted that herbicide resistant weedy rice populations would develop quite quickly, within 3 to 8 years[2].

The EU has a moral obligation to undertake the most thorough and exhaustive analysis of the safety of this new GM crop. It is equally bound to assess the social, economic and environmental implications in developing countries, of allowing this import, before considering any permission

Another disturbing development in rice, is the news that a California based Biotechnology Company is starting to plant two rice varieties genetically modified to produce drugs for diarrhoea. The cause for alarm at the planting of a drug producing rice in far away California is the near certain likelihood of contamination of natural rice gene pools by the genetically engineered ones. The American company Ventria Bioscience has produced GM varieties of rice in Sacramento that are engineered to produce two compounds called lactoferrin and lysozyme that are be used as drugs to treat diarrhoea. The plan is to extract these compounds from the GM rice since that would be much cheaper than setting up a factory. As with many other industrial products, the question is ‘cheaper’ for whom? The Ventria

GM rice poses a serious hazard to rice growing regions because as we have seen in the past, crops produced in one region easily land up in other regions through the channels of trade or because people just carry the produce to another country.

The American Starlink corn, which is a GM corn carrying a Bt gene was not approved for use as human food since it had an allergy producing tendency. Starlink corn was however approved by the US department of Agriculture for use as animal feed. To no one’s surprise, Starlink corn was found mixed up in food articles in Japan! The reason is simple and therefore worrying. It is very difficult, if not impossible, to segregate two versions of the same product in real life. One can make complex segregation plans on paper, as Ventria is undoubtedly doing but the likelihood of mix-ups is high because field operations over hundreds of hectare are not like the tightly controlled conditions of laboratories. Contamination of one type of crop produce with another is almost certain. And if American corn could land up in Japan, what is to prevent American rice landing up in India, especially when California is a large exporter of rice.

Another contamination episode with corn should teach us a lesson about centres of origin. Whether through international trade or through human traffic, GM corn has landed up in Mexico, and contaminated the natural gene pool of corn there. Mexico, which is a centre of origin for corn, has had a ban on the planting of GM corn since 1998, yet GM corn found its way there and has crossed with Mexican corn. The contamination is assumed to have come from two sources, one, from American exports of corn to Mexico and two, from Mexicans bringing in American seeds for planting. The fact of the corn contamination has caused great distress in Mexico where corn is not just the staple food but also plays a central role in the cultural heritage of the local people, like rice does for us. Mexico moved to take strong action after the contamination was detected and has banned even research on GM corn, to cut down all sources of contamination. It is however proving to be difficult to contain the situation since corn exports to Mexico are not being stopped due to American pressure.

In the case of the Ventria rice, US rice exports (the US is the second largest exporter of rice in the world and California is the principle rice-growing region in the US) will ensure that it is carried to other countries. A contamination scenario similar to the Mexican corn case would be a highly likely event in rice growing countries and centres of origin, with consequences that cannot be predicted. At the very least, the pharmaceutical rice could end up in the food chain and people could end up eating rice with diarrhoea drugs in it.

Rice is the staple food of over half the world’s population. For about two billion people in Asia alone, rice and rice products are the main source of food. Recognizing the centrality of rice to global food security, the UN has declared 2004 as the International Year of Rice. This is meant to focus on the threats facing rice production across the world and to develop a strategy for ensuring that sufficient rice is produced for the growing world population. The issue of genetic contamination, in the natural gene pools of rice is therefore a serious one. It is the genes found in centres of diversity like India, that enable rice cultivation to remain viable, despite natural stress like disease and drought. If such genes were to be lost or silenced, the future of rice cultivation could be in jeopardy.

The threat of genetic contamination from alien genes like those producing diarrhoea drugs is the last thing that stagnating rice productivity needs. So little is known about the long-term consequences of foreign genes moving into crop species, and almost nothing is known in the case of rice. It would be foolhardy to take a risk with a crop that feeds over half the world. May be nothing will go seriously wrong but if we were to discover 50 years down the line that foreign genes had resulted in the silencing of important genes in rice, there is nothing we could do to rectify the situation then.

The UN has declared 2004 to be the International Year of Rice in acknowledgement of the central role this cereal plays in global food security. Nearly half the world’s population eats rice as its staple food. The reason for focusing on rice is the fear of shortages because of declining productivity in some parts of the world and the burgeoning world population. In this backdrop, genetically modified rice is being discussed as an answer and both public sector and private sector research institutions in India and elsewhere, have launched projects to produce GM rice with various properties. Golden Rice is already well known, there are efforts to introduce resistance to fungal diseases, researchers are working to produce herbicide tolerant rice, similar to Monsanto’s Roundup Ready corn and Mahyco, the company that gave us Bt cotton, is working, along with other research institutions, to produce a Bt rice. Other rice projects are attempting to change the quality of rice starch and disturbingly, a private company is producing rice containing the Bt cry9C gene, which is the gene used in Starlink corn, suspected of having allergenic properties and therefore banned for human use by the USDA!

The UN must protest America’s diarrhoea drug rice and other GM rice, as a challenge to its efforts to secure the future of rice and point out the potential threat of such developments to rice producing regions and global food security. India and other countries in Asia must take the lead in orchestrating such a protest. America’s economic interest in producing cheaper drugs cannot be allowed to jeopardize the food security of half the world.

The author can be reached at mail@genecampaign.org and www.genecampaign.org



[1] Chen LJ et al. (2004) Gene flow from cultivated rice (Oryza sativa) to its weedy and wild relatives

Annals of Botany 93 (1): 67-73

[2] Madsen KH, Valverde BE, Jensen JE (2002) Risk assessment of herbicide-resistant crops: A Latin American perspective using rice (Oryza sativa) as a model Weed 16 (1): 215-223

Monday, May 3, 2004

GM OR GM FREE, WHAT IS INDIA’S USP?

SUMAN SAHAI

The Task Force on Agbiotechnology chaired by MS Swaminathan has just submitted its report to the government. An important recommendation in the report is that India’s program for developing GM crops should acknowledge the reality of the market. One of the crops mentioned in the report as needing special attention, is soybean. This should be taken serious note of by the policy planners. India is a tiny producer of soybean; the total output peaked last year at about 3.5 million tons. All India’s soybean is GM free. The US alone produces over 32 million tonnes of Soya per year 75% of which is genetically modified, Argentina produces about 28 million tonnes, 98% of which is genetically modified and there are other cultivators like Brazil which are expanding their acreage of GM Soya rapidly.

Should India start to cultivate genetically modified soybean as the Department of Biotechnology (DBT) and the Indian Council of Agricultural Research (ICAR) is promoting? What is a better course of action for our farmers? GM Soya or non-GM Soya? At present India’s entire Soybean crop is sold (3 tonnes in 2002-03). If it were to double its production, every single bean would still be sold. The reason is that it is one of the few countries from where non-GM soy can be sourced without risk of contamination, since the country does not cultivate GM soy at all and can easily certify its soybean as GM-free.

The Indian soy is supplied to niche markets that are seeking assured GM free produce. The bulk of the soybean cultivated in the world is now genetically modified and when GM free soya is available, it is from countries that are large producers of GM Soya where mixture is certain. Even in the EU where there was a de facto moratorium on GM foods, 25% of the soya produced is genetically modified and in Japan where there is a growing opposition to GM foods, 40% of the soybean is genetically engineered.

India’s USP is that it is the only country in the world that is producing 100% GM free soybean. Today all the soy that India produces is sold. Even if it were to increase its soy production several fold, all the Soya would still be sold because the international market is increasingly seeking GM free foods due to the growing rejection by consumers. Manufacturers of baby foods and convalescent foods and housewives in countries like Japan and Korea, large soy consumers, are strongly opposed to GM foods and prefer GM free Soya.

Under these circumstances, resolutely remaining a non- GM producer of soybean best serves the interest of Indian farmers. If it were to become a producer of GM soy, it would loose its special markets. Its GM soy would not be able to compete with huge producers like the US and its highly subsidized, low cost Soya. So does it make sense for India to forego its special status, lose a secure market for its produce and incomes for its farmers and start cultivating GM soybean that no one will buy?

In the case of rice, India exports not just Basmati, but non-Basmati rice as well, largely to Europe and West Asia but also to Africa. The total annual value of India’s rice export is in the vicinity of Rs. 6000 crores. The importers of Indian rice are countries where there is mounting opposition to GM foods. Indian rice enjoys assured markets today and there is a distinct upward trend in exports of both Basmati and non-basmati rice. Does it seem like an intelligent act to jeopardize this assured market and start cultivating GM rice? Who will make up for the revenue losses to the farmers that will result from countries declining the import of GM rice from India?

As against this push GM at all costs approach, it would be wise to take cognizance of the burgeoning organic sector and respond to it. The hill states have understood this simple logic. Sikkim, Nagaland, Meghalaya and Uttaranchal have decided to go organic rather than GM. The international organic market does not permit GM contamination in organic produce, so organic and GM free has to go hand in hand. This would appear to be the future that the markets are pointing to but India’s biotech policy makers seem to be oblivious to the reality of the world. Full of misplaced zeal and the desire to join the GM bandwagon at all costs, even if through copy cat research with borrowed genes, the biotech bunch are willing to play with the livelihoods of farmers by chasing a personal agenda rather that looking for the public interest.

Given the ad hoc and apparently mindless nature of decisions that are being taken on GM crops and foods by a small coterie of people, it has become a critical imperative to conduct a broad based and transparent debate on what should constitute the nation’s policy on GM crops. It is embarrassing that a country of this size and with once formidable skills, with such agricultural strengths and dependencies, is lurching from biotech product to product with no defined policy to guide it and no consultation with the public to ask what it wants.